SERPINA1
SERPINA1 (serpin family A member 1), also known as alpha-1-antitrypsin, AAT, A1AT or alpha1AT, is a secreted serine protease inhibitor of the serpin superfamily. Its major physiological role is protecting the lower respiratory tract from proteolytic destruction by leukocyte elastase. Browse Assay Genie's current range of SERPINA1 research reagents below, or read on for the biology behind the target.
SERPINA1 is a serine protease inhibitor that acts as a reversible inhibitor of chymotrypsin. It also inhibits elastase, but not trypsin. Its major physiological function is the protection of the lower respiratory tract against proteolytic destruction by human leukocyte elastase (HLE). The NCBI Gene summary lists a broader set of targets for this serpin superfamily member, including elastase, plasmin, thrombin, trypsin, chymotrypsin and plasminogen activator.
The SERPINA1 gene encodes a protein of the serpin family, assigned by HGNC to the serpin peptidase inhibitors group. The protein is mainly found as a secreted species, with annotated locations in the endoplasmic reticulum and in the extracellular matrix. It is produced in the liver, in the bone marrow, by lymphocytic and monocytic cells in lymphoid tissue, and by the Paneth cells of the gut. Several transcript variants have been described, and all encode the same protein. The rat ortholog is Serpina1.
Defects in the SERPINA1 gene are associated with chronic obstructive pulmonary disease, emphysema and chronic liver disease, which makes the protein a frequent subject in respiratory and hepatic research. The protein has accumulated many names: alpha-1-antitrypsin, AAT, A1A, A1AT, alpha1AT, PI1 and PI. Earlier gene names described it as serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1. Researchers studying SERPINA1 protein levels or expression should match reagents to their species and application.
SERPINA1 protects the lower respiratory tract from leukocyte elastase, and its defects are associated with chronic obstructive pulmonary disease and emphysema.
Defects in SERPINA1 are associated with chronic liver disease, and the protein is produced in the liver.
As a serpin, it inhibits elastase and chymotrypsin, and its listed targets include plasmin, thrombin and plasminogen activator.
SERPINA1 is made by lymphocytic and monocytic cells in lymphoid tissue, in bone marrow and by gut Paneth cells.
SERPINA1 is a serpin that inhibits serine proteases. It reversibly inhibits chymotrypsin and also inhibits elastase, but not trypsin. Its major physiological function is protecting the lower respiratory tract from proteolytic destruction by human leukocyte elastase.
SERPINA1 is widely called alpha-1-antitrypsin, abbreviated AAT, A1AT or alpha1AT. Other aliases are A1A, PI1 and PI. Older gene names refer to serine (or cysteine) proteinase inhibitor, clade A, member 1. Several transcript variants encode the same protein.
Yes. According to the NCBI Gene summary, defects in SERPINA1 are associated with chronic obstructive pulmonary disease, emphysema and chronic liver disease. A rat ortholog, Serpina1, is annotated; check the datasheet of any product for its validated reactivity.
Other members of the SERPINA clade of serpin peptidase inhibitors with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P01009; product specifications from Assay Genie datasheets.